{{Rsnum
|rsid=4312989
|Chromosome=6
|position=55945684
|Orientation=plus
|GMAF=0.2911
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 39.8 | 49.6 | 10.6
| HCB | 86.1 | 13.1 | 0.7
| JPT | 86.7 | 12.4 | 0.9
| YRI | 43.8 | 47.3 | 8.9
| ASW | 40.4 | 40.4 | 19.3
| CHB | 86.1 | 13.1 | 0.7
| CHD | 87.0 | 11.1 | 1.9
| GIH | 70.3 | 24.8 | 5.0
| LWK | 35.5 | 49.1 | 15.5
| MEX | 27.6 | 58.6 | 13.8
| MKK | 50.3 | 39.4 | 10.3
| TSI | 42.6 | 44.6 | 12.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs4312989
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19176441
|Annotation=This variant is associated with end-of-induction minimal risidual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) from 2 independent cohorts (GWAS result). Risk Allele: C, MAF= 0.34, combined P value= 2.51E-04.
|Drugs=
|Drug Classes=
|Diseases=Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma
|Curation Level=Curated
|PharmGKB Accession ID=PA162470221
}}

{{PMID Auto
|PMID=17903300
|Title=Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4312989
|overall_frequency_n=45
|overall_frequency_d=126
|overall_frequency=0.357143
|n_genomes=35
|n_genomes_annotated=0
|n_haplomes=44
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}